The Association of Blood Biomarkers and Body Mass Index in Knee Osteoarthritis: A Cross-Sectional Study
Open Access
- 29 January 2022
- journal article
- research article
- Published by SAGE Publications in CARTILAGE
- Vol. 13 (1)
Abstract
Objective: Despite massive efforts, there are no diagnostic blood biomarkers for knee osteoarthritis (KOA). This study investigated several candidate diagnostic biomarkers and the metabolic phenotype in end-stage KOA in the context of obesity. Design: In this cross-sectional study, adult patients undergoing knee arthroplasty were enrolled and KOA severity was assessed using the Lequesne index. Blood biomarkers with an important role in obesity, the metabolic syndrome, or KOA (oxidized form of low-density lipoprotein [oxLDL], advanced glycation end product [AGE], soluble AGE receptor [sRAGE], fatty acid binding protein 4 [FABP4], phospholipase A2 group IIA [PLA2G2A], fibroblast growth factor 23 [FGF-23], ghrelin, leptin, and resistin) were measured using enzyme-linked immunosorbent assay (ELISA; n = 70) or Luminex technique (subgroup of n = 35). H1-NMR spectroscopy was used for the quantification of metabolite levels (subgroup of n = 31). The hip-knee-ankle angle was assessed. Multivariable and multivariate regression analysis was used to examine the relationship of biomarkers with body mass index (BMI) and KOA severity in complete case and multiple imputation analysis. Results: While most of the investigated biomarkers were not associated with KOA severity, FABP4 and leptin were found to correlate with BMI and gender. Resistin was associated with Lequesne index in complete case analysis. Using a targeted metabolomics approach, BMI-dependent changes in the metabolome were hardly visible. Conclusions: Our findings confirm studies on FABP4, leptin, and resistin with regard to obesity and the metabolic syndrome. There was no association of the investigated biomarkers with KOA severity, most likely due to the patient selection (end-stage KOA patients). Based on this absence of BMI-dependent changes in the metabolome, we might assume that BMI is not correlated with KOA severity in this specific patient group.Keywords
Funding Information
- Ludwig Boltzmann Institute for Arthritis and Rehabilitation
- Medizinische Universität Graz
This publication has 46 references indexed in Scilit:
- Bead-based multiplex immuno-assays for cytokines, chemokines, growth factors and other analytes: Median fluorescence intensities versus their derived absolute concentration values for statistical analysisCytokine, 2015
- Adipokines correlate with pain in lower limb osteoarthritis: different associations in hip and kneeInternational Orthopaedics, 2014
- The global burden of hip and knee osteoarthritis: estimates from the Global Burden of Disease 2010 studyAnnals of the Rheumatic Diseases, 2014
- The association of adipokine levels in plasma and synovial fluid with the severity of knee osteoarthritisRheumatology, 2013
- Metabolic syndrome meets osteoarthritisNature Reviews Rheumatology, 2012
- Serum adipokines in osteoarthritis; comparison with controls and relationship with local parameters of synovial inflammation and cartilage damageOsteoarthritis and Cartilage, 2012
- Multiple phospholipase A2 enzymes participate in the inflammatory process in osteoarthritic cartilageScandinavian Journal of Rheumatology, 2011
- mice: Multivariate Imputation by Chained Equations inRJournal of Statistical Software, 2011
- Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)JAMA, 2001
- Indexes of Severity for Osteoarthritis of the Hip and Knee:Validation–Value in Comparison with Other Assessment TestsScandinavian Journal of Rheumatology, 1987